Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$5.16
-0.16-3.01%
At close: -
$4.91
-0.25-4.84%
After Hours: Apr 4, 7:18 PM EDT
Comments
Loading...
LifeMD Analyst Ratings and Price Targets | NASDAQ:LFMD | Benzinga
LifeMD Inc has a consensus price target of $12 based on the ratings of 8 analysts. The high is $15 issued by Cantor Fitzgerald on March 11, 2025. The low is $7 issued by Keybanc on January 8, 2025. The 3 most-recent analyst ratings were released by HC Wainwright & Co., Cantor Fitzgerald, and Keybanc on March 12, 2025, March 11, 2025, and January 8, 2025, respectively. With an average price target of $12 between HC Wainwright & Co., Cantor Fitzgerald, and Keybanc, there's an implied 144.40% upside for LifeMD Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
Cantor Fitzgerald
Keybanc
Lake Street
Mizuho
1calculated from analyst ratings
Analyst Ratings for LifeMD
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 03/12/2025 | Buy Now | 185.13% | HC Wainwright & Co. | Yi Chen56% | $12 → $14 | Maintains | Buy | Get Alert |
| 03/11/2025 | Buy Now | 205.5% | Cantor Fitzgerald | Sarah James52% | $15 → $15 | Reiterates | Overweight → Overweight | Get Alert |
| 01/08/2025 | Buy Now | 42.57% | Keybanc | Scott Schoenhaus41% | $10 → $7 | Maintains | Overweight | Get Alert |
| 12/10/2024 | Buy Now | 144.4% | Lake Street | Brooks O'Neil35% | → $12 | Initiates | → Buy | Get Alert |
| 12/04/2024 | Buy Now | 42.57% | Mizuho | Steven Valiquette59% | → $7 | Initiates | → Neutral | Get Alert |
| 11/11/2024 | Buy Now | 144.4% | HC Wainwright & Co. | Yi Chen56% | $12 → $12 | Reiterates | Buy → Buy | Get Alert |
| 09/20/2024 | Buy Now | 205.5% | Cantor Fitzgerald | Sarah James52% | $15 → $15 | Reiterates | Overweight → Overweight | Get Alert |
| 08/20/2024 | Buy Now | 205.5% | Cantor Fitzgerald | Sarah James52% | $15 → $15 | Reiterates | Overweight → Overweight | Get Alert |
| 08/09/2024 | Buy Now | 205.5% | Cantor Fitzgerald | Sarah James52% | $15 → $15 | Reiterates | Overweight → Overweight | Get Alert |
| 07/11/2024 | Buy Now | 103.67% | Keybanc | Scott Schoenhaus41% | $12 → $10 | Maintains | Overweight | Get Alert |
| 06/05/2024 | Buy Now | 144.4% | Keybanc | Scott Schoenhaus41% | → $12 | Initiates | → Overweight | Get Alert |
| 05/21/2024 | Buy Now | 144.4% | B. Riley Securities | William Woods23% | → $12 | Reiterates | Buy → Buy | Get Alert |
| 05/10/2024 | Buy Now | 144.4% | HC Wainwright & Co. | Yi Chen56% | $12 → $12 | Reiterates | Buy → Buy | Get Alert |
| 05/09/2024 | Buy Now | 205.5% | Cantor Fitzgerald | Sarah James52% | $13 → $15 | Maintains | Overweight | Get Alert |
| 04/23/2024 | Buy Now | 185.13% | BTIG | David Larsen44% | $13 → $14 | Maintains | Buy | Get Alert |
| 03/15/2024 | Buy Now | 164.77% | BTIG | David Larsen44% | $11 → $13 | Maintains | Buy | Get Alert |
| 03/12/2024 | Buy Now | 144.4% | HC Wainwright & Co. | Yi Chen56% | $12 → $12 | Reiterates | Buy → Buy | Get Alert |
| 03/12/2024 | Buy Now | 205.5% | Craig-Hallum | Alex Fuhrman39% | $10 → $15 | Maintains | Buy | Get Alert |
| 03/12/2024 | Buy Now | 144.4% | B. Riley Securities | William Woods23% | $11 → $12 | Reiterates | Buy → Buy | Get Alert |
| 03/12/2024 | Buy Now | 124.03% | Cantor Fitzgerald | Sarah James52% | $9 → $11 | Maintains | Overweight | Get Alert |
| 01/11/2024 | Buy Now | 144.4% | HC Wainwright & Co. | Yi Chen56% | $10 → $12 | Maintains | Buy | Get Alert |
| 12/14/2023 | Buy Now | 83.3% | Cantor Fitzgerald | Sarah James52% | → $9 | Reiterates | Overweight → Overweight | Get Alert |
| 11/30/2023 | Buy Now | 103.67% | Craig-Hallum | Alex Fuhrman39% | → $10 | Initiates | → Buy | Get Alert |
| 11/14/2023 | Buy Now | 83.3% | Cantor Fitzgerald | Sarah James52% | $8 → $9 | Maintains | Overweight | Get Alert |
| 11/09/2023 | Buy Now | 103.67% | HC Wainwright & Co. | Yi Chen56% | $9 → $10 | Maintains | Buy | Get Alert |
| 10/02/2023 | Buy Now | 62.93% | Cantor Fitzgerald | Sarah James52% | $7 → $8 | Maintains | Overweight | Get Alert |
| 09/14/2023 | Buy Now | 42.57% | Cantor Fitzgerald | Sarah James52% | → $7 | Reiterates | Overweight → Overweight | Get Alert |
| 08/11/2023 | Buy Now | 83.3% | HC Wainwright & Co. | Yi Chen56% | → $9 | Reiterates | Buy → Buy | Get Alert |
| 07/21/2023 | Buy Now | 42.57% | Cantor Fitzgerald | Sarah James52% | → $7 | Initiates | → Overweight | Get Alert |
| 07/03/2023 | Buy Now | 83.3% | HC Wainwright & Co. | Yi Chen56% | → $9 | Initiates | → Buy | Get Alert |
| 03/23/2023 | Buy Now | 42.57% | BTIG | David Larsen44% | $8 → $7 | Maintains | Buy | Get Alert |
FAQ
What is the target price for LifeMD (LFMD) stock?
The latest price target for LifeMD (NASDAQ:LFMD) was reported by HC Wainwright & Co. on March 12, 2025. The analyst firm set a price target for $14.00 expecting LFMD to rise to within 12 months (a possible 185.13% upside). 15 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for LifeMD (LFMD)?
The latest analyst rating for LifeMD (NASDAQ:LFMD) was provided by HC Wainwright & Co., and LifeMD maintained their buy rating.
When was the last upgrade for LifeMD (LFMD)?
There is no last upgrade for LifeMD
When was the last downgrade for LifeMD (LFMD)?
There is no last downgrade for LifeMD.
When is the next analyst rating going to be posted or updated for LifeMD (LFMD)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of LifeMD, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for LifeMD was filed on March 12, 2025 so you should expect the next rating to be made available sometime around March 12, 2026.
Is the Analyst Rating LifeMD (LFMD) correct?
While ratings are subjective and will change, the latest LifeMD (LFMD) rating was a maintained with a price target of $12.00 to $14.00. The current price LifeMD (LFMD) is trading at is $4.91, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.